Journal article 972 views
A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
Fabrizio Pertusati,
Salvatore Ferla 
,
Marcella Bassetto,
Andrea Brancale,
Sahar Khandil,
Andrew D. Westwell,
Christopher McGuigan
,
Marcella Bassetto,
Andrea Brancale,
Sahar Khandil,
Andrew D. Westwell,
Christopher McGuigan
European Journal of Medicinal Chemistry, Volume: 180, Pages: 1 - 14
Swansea University Authors:
Salvatore Ferla , Marcella Bassetto
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.ejmech.2019.07.001
Abstract
A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
| Published in: | European Journal of Medicinal Chemistry |
|---|---|
| ISSN: | 0223-5234 |
| Published: |
Elsevier BV
2019
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa52218 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Keywords: |
Pentafluorosulfanyl; Pentafluoroethyl; Prostate cancer; Androgen receptor; Antiproliferative activity; Enobosarm; Bicalutamide; Enzalutamide |
|---|---|
| College: |
Faculty of Science and Engineering |
| Start Page: |
1 |
| End Page: |
14 |